PD-009Emergence of KRAS mutation may play a major role in the secondary resistance to EGFR blockade

In this study, we tried to clarify the mechanism of primary or secondary resistance to EGFR blockade as first-line treatment of metastatic colorectal cancer.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research